(Q38329458)

2 September 2017

Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells (English)

1 reference

2 September 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

Paul B-S Lai

4

0 references

Jeremy A. Squire

object named as

Jeremy A Squire

5

0 references

author name string

Elizabeth Pang

1

1 reference

2 September 2017

Ying Hu

2

1 reference

2 September 2017

Kathy Y-Y Chan

3

1 reference

2 September 2017

Pascale F Macgregor

6

1 reference

2 September 2017

Ben Beheshti

7

1 reference

2 September 2017

Monique Albert

8

1 reference

2 September 2017

Thomas W-T Leung

9

1 reference

2 September 2017

Nathalie Wong

10

1 reference

2 September 2017

language of work or name

1 reference

1 May 2005

1 reference

2 September 2017

Laboratory Investigation

1 reference

2 September 2017

85

1 reference

2 September 2017

5

1 reference

2 September 2017

664-674

1 reference

describes a project that uses

2 September 2017

0 references

0 references

0 references

0 references

0 references

https://scigraph.springernature.com/pub.10.1038/labinvest.3700254

0 references

cites work

Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Tumor cell resistance to DNA topoisomerase II inhibitors: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Strategies for reversing drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

The effect of different interventional treatment on P-Glycoprotein in different histopathological types and grades of primary hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Atypical multidrug resistance may be associated with catalytically active mutants of human DNA topoisomerase II alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Markers of drug resistance in relapsing colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

inferred from DOI database lookup

7 January 2021

based on heuristic

Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxorubicin: implications for the mechanisms of doxorubicin action and cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700254

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.3700254

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference